Clinical Trial Update: Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer [NA]

View source ↗

Summary

This clinical trial update reports a completed study evaluating L-T3 (liothyronine) for follow-up in patients with thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• L-T3 (liothyronine) (liothyronine)

Snippet

Sponsor: Patrice Perron | Conditions: Thyroid Cancer | NA | Status: COMPLETED